Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does THIOTEPA Cause Disease progression? 153 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 153 reports of Disease progression have been filed in association with THIOTEPA (Thiotepa). This represents 2.2% of all adverse event reports for THIOTEPA.

153
Reports of Disease progression with THIOTEPA
2.2%
of all THIOTEPA reports
67
Deaths
16
Hospitalizations

How Dangerous Is Disease progression From THIOTEPA?

Of the 153 reports, 67 (43.8%) resulted in death, 16 (10.5%) required hospitalization, and 12 (7.8%) were considered life-threatening.

Is Disease progression Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for THIOTEPA. However, 153 reports have been filed with the FAERS database.

What Other Side Effects Does THIOTEPA Cause?

Off label use (762) Febrile neutropenia (645) Mucosal inflammation (616) Cytomegalovirus infection (446) Product use in unapproved indication (425) Pyrexia (359) Drug ineffective (358) Acute graft versus host disease in skin (355) Acute graft versus host disease (331) Cytomegalovirus infection reactivation (325)

What Other Drugs Cause Disease progression?

RITUXIMAB (7,282) CYCLOPHOSPHAMIDE (7,100) DOXORUBICIN (6,165) VINCRISTINE (5,252) PREDNISONE (5,096) BEVACIZUMAB (4,653) DEXAMETHASONE (4,545) CARBOPLATIN (4,538) CAPECITABINE (3,808) ETOPOSIDE (3,776)

Which THIOTEPA Alternatives Have Lower Disease progression Risk?

THIOTEPA vs THIOTHIXENE THIOTEPA vs THROMBIN THIOTEPA vs THROMBIN HUMAN THIOTEPA vs THYMOCYTE IMMUNE GLOBULIN NOS THIOTEPA vs THYMOGLOBULINE

Related Pages

THIOTEPA Full Profile All Disease progression Reports All Drugs Causing Disease progression THIOTEPA Demographics